Therapeutic Application of Crude Mitochondrial Transplantation for Diabetic Wound Healing /
Farhan Hameed
- 77p. Soft Copy 30cm
Chronic wounds in diabetic condition pose a persistent clinical challenge, primarily due to impaired cellular energy metabolism and delayed tissue regeneration. Mitochondrial dysfunction plays pivotal role in this impaired healing process, making mitochondrial transplantation (MT) a promising therapeutic strategy. This study investigates the efficacy of MT in accelerating wound repair using a diabetic mice model. Full-thickness excisional wounds (6mm) were created on the dorsal surface of diabetic mice, followed by subcutaneous administration of isolated crude mitochondria at low, moderate and high dose (5ug, 10ug, and 20ug) mitochondria per wound. A vehicle-treated group receiving phosphate-buffered saline (PBS) served as the control. Mitochondrial viability and quantification were assessed using MTT assay and Bradford in wound contraction. Wound closure analysis revealed a dose-dependent acceleration of healing, with high-dose group exhibiting the most significant improvement in wound contraction and re-epithelialization. Histological analysis confirmed enhanced tissue regeneration in the treatment groups. Furthermore real-time PCR analysis demonstrated a significant upregulation of RAC1, CDC42, and VEGF in the moderate and high treatment groups, indicating enhanced cytoskeletal remodeling, cellular migration and angiogenesis. These findings highlight the therapeutic potential of crude mitochondrial transplantation in diabetic wound healing by restoring cellular bioenergetics and promoting tissue repair. This approach offers a promising regenerative strategy for managing chronic wound and improving diabetic wound outcomes.